Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published February 18, 2013.
Author Disclosures
- Megan Hyland, MD,
- Robert A. Bermel, MD and
- Jeffrey A. Cohen, MD
- Megan Hyland, MD,
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Robert A. Bermel, MD and
Novartis, Questcor
NONE
Biogen Idec, Teva Neuroscience, Novartis
NONE
NONE
NONE
NONE
Biogen Idec, Teva Neuroscience, Astellas
NONE
NONE
NONE
Novartis
NONE
NONE
National Multiple Sclerosis Society Research Grant RG4449A1/T
NONE
NONE
NONE
NONE
NONE
NONE
- Jeffrey A. Cohen, MD
Biogen Idec3/11/2011, Consulting meeting, $9100Elan12/10/2010, Consulting meeting, $2250Novartis11/19/2010, Consulting meeting, $6600Teva4/22/2011, Consulting meeting, $36001/23/2012, Consulting meeting, $2500Vaccinex5/15/2011, Consulting meeting, $4000
NONE
Novartis4/12/2011, Speaker, $2500
NONE
NONE
Cambridge University Press, JA Cohen and RA Rudick, eds, Multiple Sclerosis Therapeutics, 4th edition, 2011
NONE
NONE
NONE
NONE
NONE
Research support paid to my institution from: Biogen Idec, Genzyme, Novartis, Receptos, Synthon, Teva
Department of Defense, PR093324, PI, 2010-14NIH, 1 RO1 NS074787, 2011-4
NONE
Nancy Davis Center Without Walls, 2007, $25,000Nancy Davis Center Without Walls, 2008, $25,000
NONE
NONE
NONE
NONE
NONE
NONE
- Department of Neurology (MH), University of Rochester Medical Center, Rochester, NY; and Mellen Center for MS Treatment and Research (RAB, JAC), Neurological Institute, Cleveland Clinic, Cleveland, OH.
- Correspondence to:
megan_hyland{at}urmc.rochester.edu
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Views & Reviews
Diffusion MRI in multiple sclerosisM. Rovaris, A. Gass, R. Bammer et al.Neurology, November 21, 2005 -
Articles
Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesionsN. Abou Zeid, I. Pirko, B. Erickson et al.Neurology, May 09, 2012 -
Articles
Association of innate immune activation with latent Epstein-Barr virus in active MS lesionsJ.S. Tzartos, G. Khan, A. Vossenkamper et al.Neurology, December 07, 2011 -
Article
Magnetic resonance frequency shifts during acute MS lesion formationVanessa Wiggermann, Enedino Hernández Torres, Irene M. Vavasour et al.Neurology, June 12, 2013